115/09/05 14:20 - 115/09/06 12:00

下載  

高雄洲際酒店

謝燿宇 醫師、郭明濬 醫師、顏志傑 醫師 、謝孟哲 醫師、廖浚凱 醫師 蕭聖諺 醫師、張家崙 醫師

高雄市南屏癌症防治衛教學會

1. One Target, Multiple Cancers: Advancing BRAF V600E Treatment
課程摘要：
BRAF V600E is a well-established oncogenic driver mutation identified across multiple solid tumors, including melanoma, colorectal cancer, non-small cell lung cancer (NSCLC). BRAF V600E–mutated metastatic colorectal cancer (mCRC) is an aggressive subtype with poor prognosis. Traditional chemotherapy offers limited benefit, leading to the rise of targeted strategies. Dual BRAF and EGFR inhibition, exemplified by encorafenib-based therapy, has improved survival outcomes. Ongoing studies focus on optimizing combinations, integrating novel targets and immunotherapy, and refining patient selection through biomarkers and real-world data—advancing precision oncology in this challenging disease.(其餘內容詳見附件摘要)

廖秀雲

0970823093

hsiuyun30@gmail.com